The eligibility criteria can consider many factors besides the tumor size and numbers, such as tumor biology (including alpha-fetoprotein (AFP) concentration), but tumor size is usually the obstacle for HCC patients along with the availability of donor organs and the composition of the waitlist [28]. This evidence concerns the gene AFP and hepatocellular carcinoma.